CC
INO icon

Centiva Capital’s Inovio Pharmaceuticals INO Stock Holding History

Centiva Capital’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,534
Closed -$24.5K – 1878
2023
Q2 		$24.5K Buy
+4,534
New +$36.5K ﹤0.01% 1535
2021
Q2 		– Sell
-1,708
Closed -$190K – 1493
2021
Q1 		$190K Buy
1,708
+724
+74% +$95.2K 0.01% 1005
2020
Q4 		$104K Sell
984
-121
-11% -$16.1K ﹤0.01% 839
2020
Q3 		$154K Buy
+1,105
New +$230K 0.01% 628

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Centiva Capital's INO Position: Q3 2023 in Review

Centiva Capital sold out of Inovio Pharmaceuticals (INO) in Q3 2023, closing a stake of 4,534 shares — an estimated $24.5K sold.

Centiva Capital first reported a position in INO in Q3 2020 and held it in 4 quarters. The position peaked at $190K in Q1 2021. 123 funds tracked by Wall St. Rank hold INO as of Q3 2023.

  • Centiva Capital reported no remaining Inovio Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Centiva Capital sold 4,534 Inovio Pharmaceuticals shares in Q3 2023, an estimated $24.5K.
  • Centiva Capital first reported a position in Inovio Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Centiva Capital's Inovio Pharmaceuticals position peaked at $190K in Q1 2021.
  • 123 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.